Feng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Feng Liu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
Jian Tang
Digestive Endoscopy Center, Shanghai Tenth People's Hospital Tongji University School of Medicine Shanghai China
3 shared publicationsJia-Su Li
Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China
2 shared publicationsJiasu Li
Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China
2 shared publications- Zhao-Shen Li
Department of Gastroenterology, Changhai Hospital, Naval Medical University, Shanghai, China
2 shared publications - Changshen Yu
Department of Neurology, Tianjin Huanhu Hospital, Tianjin, 300350, People’s Republic of China
1 shared publication - Dong Wang
Department of Pharmaceutical Sciences, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE 68198-6125, USA
1 shared publication
Latest Publications
- 9 May 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (3) , 567-568
Endoscopic Ultrasound-Guided Choledochoduodenostomy Versus Endoscopic Retrograde Cholangiopancreatography for the Primary Prevention of Pancreatitis: An Unfair Comparison
- 9 May 2026
- Published by Elsevier in Gastroenterology
- Vol. 171 (3) , 567-568
Endoscopic Ultrasound-Guided Choledochoduodenostomy Versus Endoscopic Retrograde Cholangiopancreatography for the Primary Prevention of Pancreatitis: An Unfair Comparison
- 12 May 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (9) , 1769-1779
Adverse events in endoscopic ultrasound‐guided choledochoduodenostomy with lumen‐apposing metal stents: A systematic review and meta‐analysis
Background and Aim: Several meta‐analyses have analyzed the technical and clinical success of endoscopic ultrasound‐guided choledochoduodenostomy (EUS‐CDS) by using lumen‐apposing metal stents (LAMS) in malignant biliary obstruction, but those concerning adverse events (AEs) are scarce. The current systematic review and meta‐analysis was conducted to evaluate the AEs after EUS‐CDS with LAMS.Methods: A comprehensive literature search of PubMed, Embase, Scopus, Web of Science, and the Cochrane Library was conducted for studies reporting the outcomes of EUS‐CDS with LAMS. The main endpoints were the incidence of overall and specific AEs. Moreover, the stent dysfunction, and reintervention rates were evaluated independently.Results: A total of 21 studies (n = 1438) were included in the final meta‐analysis. The pooled rate of technical and clinical success was 93.5% (95% confidence interval [CI]: 91.3–95.1) and 88.0% (95% CI: 83.9–91.1), respectively. After EUS‐CDS with LAMS, the pooled incidence of overall AEs was 20.1% (95% CI: 16.0–24.9). The estimated rate of early AEs was 10.6% (95% CI: 7.9–14.2), and late AEs was 11.2% (95% CI: 8.2–15.2). Infection/cholangitis was the commonest AE, with a pooled incidence of 6.1% (95% CI: 3.7–10.1). The estimated incidence of stent dysfunction and reintervention was 10.5% (95% CI: 7.5–14.4), and 12.1% (95% CI: 9.3–15.7), respectively.Conclusion: Despite with a high technical and clinical success rate, EUS‐CDS with LAMS may be associated with overall AEs and stent dysfunction in one‐fifth and one‐tenth of cases, respectively. Further efforts are required to optimize its safety and long‐term stent patency.
- 12 May 2024
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 39 (9) , 1769-1779
Adverse events in endoscopic ultrasound‐guided choledochoduodenostomy with lumen‐apposing metal stents: A systematic review and meta‐analysis
Background and Aim: Several meta‐analyses have analyzed the technical and clinical success of endoscopic ultrasound‐guided choledochoduodenostomy (EUS‐CDS) by using lumen‐apposing metal stents (LAMS) in malignant biliary obstruction, but those concerning adverse events (AEs) are scarce. The current systematic review and meta‐analysis was conducted to evaluate the AEs after EUS‐CDS with LAMS.Methods: A comprehensive literature search of PubMed, Embase, Scopus, Web of Science, and the Cochrane Library was conducted for studies reporting the outcomes of EUS‐CDS with LAMS. The main endpoints were the incidence of overall and specific AEs. Moreover, the stent dysfunction, and reintervention rates were evaluated independently.Results: A total of 21 studies (n = 1438) were included in the final meta‐analysis. The pooled rate of technical and clinical success was 93.5% (95% confidence interval [CI]: 91.3–95.1) and 88.0% (95% CI: 83.9–91.1), respectively. After EUS‐CDS with LAMS, the pooled incidence of overall AEs was 20.1% (95% CI: 16.0–24.9). The estimated rate of early AEs was 10.6% (95% CI: 7.9–14.2), and late AEs was 11.2% (95% CI: 8.2–15.2). Infection/cholangitis was the commonest AE, with a pooled incidence of 6.1% (95% CI: 3.7–10.1). The estimated incidence of stent dysfunction and reintervention was 10.5% (95% CI: 7.5–14.4), and 12.1% (95% CI: 9.3–15.7), respectively.Conclusion: Despite with a high technical and clinical success rate, EUS‐CDS with LAMS may be associated with overall AEs and stent dysfunction in one‐fifth and one‐tenth of cases, respectively. Further efforts are required to optimize its safety and long‐term stent patency.
- 19 August 2023
- Published by Elsevier in Gastroenterology
- Vol. 166 (3) , 538-539
Endoscopic Ultrasound-Guided Choledochoduodenostomy Using Lumen-Apposing Metal Stents vs Endoscopic Retrograde Cholangiopancreatography: Further Efforts Are Required
- 19 August 2023
- Published by Elsevier in Gastroenterology
- Vol. 166 (3) , 538-539
Endoscopic Ultrasound-Guided Choledochoduodenostomy Using Lumen-Apposing Metal Stents vs Endoscopic Retrograde Cholangiopancreatography: Further Efforts Are Required
- 1 May 2023
- Published by Wolters Kluwer Health in Pancreas
- Vol. 52 (5) , e306
Design Flaws in Study of Prophylaxis of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis
- 1 May 2023
- Published by Wolters Kluwer Health in Pancreas
- Vol. 52 (5) , e306
Design Flaws in Study of Prophylaxis of Postendoscopic Retrograde Cholangiopancreatography Pancreatitis
- Open Access
- 22 September 2022
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 7449-7457
Association of Red Blood Cell Distribution Width with Stroke Prognosis Among Patients with Small Artery Occlusion: A Hospital-Based Prospective Follow-Up Study
Objective: Stroke is the leading cause of mortality and disability worldwide. However, there is no study on the relationship between red blood cell distribution width and the prognosis of small artery occlusion, which is a stroke subtype. This study aimed to assess the association of red blood cell distribution width at admission with outcomes among patients with small artery occlusion. Methods: In this hospital-based follow-up study, all included patients were diagnosed with small artery occlusion. Outcomes included death, recurrence, and dependency at 3, 12, and 36 months after stroke onset. Multivariate analysis was performed to explore the association of red blood cell distribution width with stroke outcomes. Results: This study included 1576 patients with small artery occlusion who were followed up at 3, 12, and 36 months. For every unit increase in red blood cell distribution width, the risk of stroke recurrence and dependency increased by 5.1% (95% CI 1.002– 1.102, P=0.039) at 3 months after stroke onset. At the 12-month follow-up, for every unit increase in red blood cell distribution width, the risk of stroke recurrence increased by 3.4% (95% CI 1.000– 1.069, P=0.047). However, the relationship between red blood cell distribution width and mortality rate was not significant at 36 months after stroke onset after adjustment of covariates. Conclusion: Red blood cell distribution width is an important hematological index of small artery occlusion. It may be used to predict the recurrence of acute ischemic stroke in small artery occlusion. Therefore, patients with higher baseline values of red blood cell distribution width may need more risk factor control to reduce recurrence and dependency.
- 22 September 2022
- Published by Taylor & Francis in International Journal of General Medicine
- Vol. ume 15, 7449-7457
Open AccessAssociation of Red Blood Cell Distribution Width with Stroke Prognosis Among Patients with Small Artery Occlusion: A Hospital-Based Prospective Follow-Up Study
Objective: Stroke is the leading cause of mortality and disability worldwide. However, there is no study on the relationship between red blood cell distribution width and the prognosis of small artery occlusion, which is a stroke subtype. This study aimed to assess the association of red blood cell distribution width at admission with outcomes among patients with small artery occlusion. Methods: In this hospital-based follow-up study, all included patients were diagnosed with small artery occlusion. Outcomes included death, recurrence, and dependency at 3, 12, and 36 months after stroke onset. Multivariate analysis was performed to explore the association of red blood cell distribution width with stroke outcomes. Results: This study included 1576 patients with small artery occlusion who were followed up at 3, 12, and 36 months. For every unit increase in red blood cell distribution width, the risk of stroke recurrence and dependency increased by 5.1% (95% CI 1.002– 1.102, P=0.039) at 3 months after stroke onset. At the 12-month follow-up, for every unit increase in red blood cell distribution width, the risk of stroke recurrence increased by 3.4% (95% CI 1.000– 1.069, P=0.047). However, the relationship between red blood cell distribution width and mortality rate was not significant at 36 months after stroke onset after adjustment of covariates. Conclusion: Red blood cell distribution width is an important hematological index of small artery occlusion. It may be used to predict the recurrence of acute ischemic stroke in small artery occlusion. Therefore, patients with higher baseline values of red blood cell distribution width may need more risk factor control to reduce recurrence and dependency.
- 1 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7) , 2129-2130
Chemoradiotherapy for T1bN0M0 Esophageal Squamous Cell Carcinoma: A Practical Dilemma Delimited by Invasion Depth
- 1 June 2022
- Published by Elsevier in Gastroenterology
- Vol. 162 (7) , 2129-2130
Chemoradiotherapy for T1bN0M0 Esophageal Squamous Cell Carcinoma: A Practical Dilemma Delimited by Invasion Depth
- Open Access
- 10 March 2022
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 811005
Comparison of Choledochoduodenostomy and Hepaticogastrostomy for EUS-Guided Biliary Drainage: A Meta-Analysis
Background: Although endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) or hepaticogastrostomy (EUS-HGS) has emerged as an option for patients of failed endoscopic retrograde cholangiopancreatography (ERCP), there has no agreement on which approach is preferred. Therefore, a meta-analysis was performed to examine the two methods.Methods: We performed a comprehensive search in databases of PubMed, Embase, and Cochrane library to find relevant studies reporting the efficacy and safety of the two EUS-guided biliary drainage methods.Results: In total, 12 studies with 623 patients (EUS-CDS: 303 and EUS-HGS: 320) were included. The cumulative technical success and clinical success for EUS-CDS and EUS-HGS was 95.0% (288/303), 93.1% (268/288), and 96.6% (309/320), 91.3% (282/309), respectively. Compared with EUS-HGS, the pooled odds ratio (OR) was 0.74 (95% CI 0.33–1.65; p = 0.46) for EUS-CDS technical success and 0.94 (95% CI 0.56–1.59; p = 0.83) for clinical success. The pooled difference in means of procedure time of EUS-CDS and EUS-HGS was −2.68 (95% CI −5.12 to −0.24; p = 0.03). The cumulative early adverse events for EUS-CDS and EUS-HGS was 12.2% (37/303) and 17.5% (56/320), respectively. Compared with EUS-HGS, the pooled OR of early adverse events for EUS-CDS was 0.58 (95% CI: 0.36–0.93; p = 0.02).Conclusion: This meta-analysis further suggests EUS-CDS and EUS-HGS have equal high technical and clinical success, but EUS-CDS with a slightly short procedure time and with less early adverse events compared to EUS-HGS.
- 10 March 2022
- Published by Frontiers Media SA in Frontiers in Surgery
- Vol. 9, 811005
Open AccessComparison of Choledochoduodenostomy and Hepaticogastrostomy for EUS-Guided Biliary Drainage: A Meta-Analysis
Background: Although endoscopic ultrasound-guided choledochoduodenostomy (EUS-CDS) or hepaticogastrostomy (EUS-HGS) has emerged as an option for patients of failed endoscopic retrograde cholangiopancreatography (ERCP), there has no agreement on which approach is preferred. Therefore, a meta-analysis was performed to examine the two methods.Methods: We performed a comprehensive search in databases of PubMed, Embase, and Cochrane library to find relevant studies reporting the efficacy and safety of the two EUS-guided biliary drainage methods.Results: In total, 12 studies with 623 patients (EUS-CDS: 303 and EUS-HGS: 320) were included. The cumulative technical success and clinical success for EUS-CDS and EUS-HGS was 95.0% (288/303), 93.1% (268/288), and 96.6% (309/320), 91.3% (282/309), respectively. Compared with EUS-HGS, the pooled odds ratio (OR) was 0.74 (95% CI 0.33–1.65; p = 0.46) for EUS-CDS technical success and 0.94 (95% CI 0.56–1.59; p = 0.83) for clinical success. The pooled difference in means of procedure time of EUS-CDS and EUS-HGS was −2.68 (95% CI −5.12 to −0.24; p = 0.03). The cumulative early adverse events for EUS-CDS and EUS-HGS was 12.2% (37/303) and 17.5% (56/320), respectively. Compared with EUS-HGS, the pooled OR of early adverse events for EUS-CDS was 0.58 (95% CI: 0.36–0.93; p = 0.02).Conclusion: This meta-analysis further suggests EUS-CDS and EUS-HGS have equal high technical and clinical success, but EUS-CDS with a slightly short procedure time and with less early adverse events compared to EUS-HGS.
- Open Access
- 1 September 2011
- Published by SAGE Publications in The American Surgeon™
- Vol. 77 (9) , 179-181
A Long-Term-Lodged Esophageal Foreign Body in an Adult Caused Esophageal Stricture and a Mediastinal Mass
- 1 September 2011
- Published by SAGE Publications in The American Surgeon™
- Vol. 77 (9) , 179-181
Open AccessA Long-Term-Lodged Esophageal Foreign Body in an Adult Caused Esophageal Stricture and a Mediastinal Mass